COVID-19 Costs Hit Insurers
April 8, 2020
They are waiving cost sharing for COVID-19 treatment. How large will premium increases be next year?
Mari Edlin
Point-of-Care Tools in Pharmacy Take Off
March 2, 2020
New point-of-care tools offer greater transparency.
Accessibility and Affordability of Gene Therapy
November 5, 2019
Payers are finding ways for members to afford expensive specialty drug treatments.
What Are Authorized Generics?
October 4, 2019
Authorized generics have been gaining popularity with pharmaceutical manufacturers, but just how do they impact pharmacies?
Drug Shortages Continue to Burden Healthcare
September 11, 2019
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
Drug Price Reform Takes Off in 2019
August 8, 2019
Opportunities to lower drug prices, as promised by President Trump’s American Patients First Blueprint, are picking up steam, some progressing more quickly than others.
Indication-based Formulary Design Chases Medicare Market
June 12, 2019
CMS introduced indication-based formularies as a voluntary tool for plans to implement in 2020.
How Payers Are Keeping Specialty Drug Costs Down
April 11, 2019
The real-world strategies used to manage the high cost of specialty meds.
The State of Drug Rebates
April 10, 2019
The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?
How Health Systems Use Pharmacists to Reduce Readmissions
April 6, 2019
The stakes have never been higher in reducing readmissions and hospitals are leveraging pharmacists’ expertise and putting them at the forefront of readmission reduction programs
